Journal of the science of food and agriculture
Cure8 research brief
Why This Matters
This preclinical study suggests a food-derived peptide formulation might reduce inflammation and improve intestinal barrier markers in lab and mouse models of ulcerative colitis, which could interest people exploring new nonpharmaceutical approaches or researchers developing oral delivery systems.
Who Should Pay Attention
Researchers studying IBD therapeutics, drug-delivery or functional-food approaches; patients and caregivers curious about preclinical dietary or supplement research (not clinical evidence).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The researchers used ultrasound-assisted enzymatic hydrolysis to make phycocyanin peptides and then encapsulated them with chitosan–sodium tripolyphosphate into nanoparticles that showed high encapsulation efficiency and improved gastrointestinal stability in lab testing.
In cell and mouse experiments the nanoparticle formulation lowered pro-inflammatory signals, increased some anti-inflammatory cytokines and tight-junction proteins, and reduced disease activity index and colon injury in mice with experimentally induced colitis.
This work identifies three short peptide sequences (YAINA, FPYTT, YVTYA) as bioactive components; the authors present the formulation as a potential functional-food ingredient for UC prevention rather than as a registered drug.
Keep In Mind
This is an abstract and preclinical study (cell and mouse experiments). Findings in animals do not establish safety or effectiveness in humans; the paper frames the product as a potential functional-food ingredient, not an approved therapy. Clinical trials would be needed before recommending use in people with UC.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of the science of food and agriculture
AuthorsZongyu Zhang, Shuang Du, Yunlong Chen +4 more
InstitutionSchool of Food Science and Engineering, Qingdao Agricultural University, Qingdao, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 19, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells
The study suggests a new mechanism—blocking HSP90-mediated necroptosis of intestinal epithelial cells—that may reduce inflammation and tissue damage in ulcerative colitis, which could guide early drug-discovery efforts.
Anti-inflammatory activity of Chlorella polysaccharide AHP.
The study reports that Chlorella-derived polysaccharide AHP reduced inflammation, supported barrier repair, and changed gut microbiota in cell and mouse colitis models—suggesting a potential new bioactive candidate for...
Mycobacterium tuberculosis PPE2 protein-derived peptide ameliorates DSS-induced colitis by depleting mast cells
This mouse study identifies a novel peptide that reduced DSS-induced colitis and points to mast cells and fibroblast–mast cell interactions as potential therapeutic targets. It also showed additive benefit when combined...